• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND BTK TURBOHAWK; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND BTK TURBOHAWK; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aneurysm (1708); Perforation (2001); Embolism/Embolus (4438); Restenosis (4576); Insufficient Information (4580)
Event Date 07/12/2021
Event Type  Injury  
Event Description
This retrospective study analyzed 79 patients (83 lesions) who were treated with directional atherectomy (silverhawk and turbohawk) and non-medtronic drug-coated balloon for femoropopliteal lesions.The target limbs were on the left in 36 patients, right in 37, and bilateral in 4.Fourteen patients had previous peripheral revascularization and 10 patients had prior intervention of the target vessel.Forty-four patients were there were 73 limbs with de novo lesion, including 23, 18, and 32 with diffused stenosis, cto, and stenosis + cto, respectively.There were 10 limbs with in-stent restenosis (isr).Target lesions involved the superficial femoral artery, popliteal artery, infrapopliteal artery, and common femoral artery in 65, 39, 5 and 7 patients, respectively.Directional atherectomy was performed at the superficial femoral artery and bifurcation area of the femoral artery in 57 and 7 patients, the p2¿p3 segment of the popliteal artery or proximal area of the infrapopliteal artery in 5 patients, and the p1 segment of the popliteal artery in 28 patients, respectively.The device and procedural success rate were both 100%.All lesions were treated via intraluminal crossing, except for 8 lesions.Retrograde pedal access was used in 3 patients.A distal embolic protection device (spider fx) was deployed in 34 lesions.Before da, 24 lesions were predilated, with a mean balloon diameter of 2.6 mm.The total length of dcb per subject was 230mm.Notably, the rate of bailout stenting was only in this cohort.Infrapopliteal runoff vessel reconstruction was performed in 45 lesions.Four patients had early perioperative complications; 1 puncture site hematoma, 2 distal embolization, 1 perforation.All patients had complete 1-year follow-up data except 2 patients who had no follow-up beyond the day of intervention.During post-procedural year, one patient with a 2-cm popliteal artery diameter was treated with a non-medtronic stent-graft in the degenerated segment.Eight patients experienced a major adverse event; 7 all-cause deaths, 1 major amputation and 1 aneurysm.
 
Manufacturer Narrative
Average age, majority gender, event date: date of article publication one-year clinical outcome and risk factor analysis of directional atherectomy followed with drug-coated balloon for femoropopliteal artery disease journal of endovascular therapy (2021) 28(6) 927¿937 10.1177/15266028211030527.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BTK TURBOHAWK
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key13050899
MDR Text Key286953453
Report Number9612164-2021-04937
Device Sequence Number1
Product Code MCW
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K170191
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient SexMale
-
-